OCGN Q3 2023 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$578M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M

Gross Profit

-$3M-90.5% margin

Operating Income

-$12M-336.1% margin

Net Income

-$12M-316.8% margin

EPS (Diluted)

$-0.06

QoQ Revenue Growth

+662.7%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$17M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$75M

Total Liabilities

$16M

Stockholders' Equity

$58M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$0	—
Gross Profit	-$3M	$0	—
Operating Income	-$12M	-$23M	+46.2%
Net Income	-$12M	-$22M	+46.6%